Vascepa is a prescription medication used to reduce the risk of cardiovascular events in certain adult patient groups [2]. The drug contains the active ingredient icosapent ethyl, which is a type of omega-3 fatty acid [3]. According to Drug Patent Watch, Vascepa is available in the form of capsules, and the recommended dosage is two capsules twice daily [1]. It is important to take Vascepa exactly as prescribed by a healthcare provider. Patients should not take more or less of the medication than recommended, and they should not stop taking it without consulting their healthcare provider [3].

The FDA approved Vascepa for use in reducing the risk of cardiovascular events in certain adult patient groups in 2019 [2]. According to the FDA, the drug is indicated for use in adult patients with triglyceride levels of 150 milligrams per deciliter or higher and other risk factors for cardiovascular disease, such as diabetes, high blood pressure, or smoking [2].

Medical News Today explains that Vascepa is typically used as part of a comprehensive treatment plan that includes lifestyle changes, such as a healthy diet and exercise [3]. Patients should continue to follow their healthcare provider's instructions regarding diet and exercise while taking Vascepa.

In conclusion, according to Drug Patent Watch, the recommended dosage for Vascepa is two capsules twice daily [1]. Vascepa is indicated for use in adult patients with triglyceride levels of 150 milligrams per deciliter or higher and other risk factors for cardiovascular disease, such as diabetes, high blood pressure, or smoking [2]. Patients should take Vascepa exactly as prescribed by their healthcare provider and should continue to follow their healthcare provider's instructions regarding diet and exercise while taking the medication [3].

Sources:
[1] https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] https://www.fda.gov/news-events/press-announcements/fda-approves-use-drug-reduce-risk-cardiovascular-events-certain-adult-patient-groups
[3] https://www.medicalnewstoday.com/articles/drugs-vascepa